A Rose by any other name? The Influence of Brand Name Versus Chemical Differences in the Prescription of Antidepressants: The Role of Expertise

Anthony Pecotich, Aron O'Cass, Craig Julian

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The effect that marketing has had on the prescription decisions of the medical profession is an area of great social and governmental concern and has been the subject of substantial international debate. In this study, the importance of brand name as a factor influencing the prescription habits of general practitioners and psychiatrists is examined. Data on antidepressant prescriptions supplied by the Australian Governments Pharmaceutical Benefit Scheme and results derived from MANOVA and ANOVA analyses suggest that the brand name as much as chemical differences influenced the prescription of choice of antidepressants by both general practitioners and psychiatrists. The use of a well-promoted brand name may be an important evaluation shortcut by both groups regardless of detailed training resulting in medical practices, which may undermine the social imperative of affordable medical care for all. The authors suggest that clinical appropriateness of prescriptions for antidepressants by brand name needs further investigation.
Original languageEnglish
Pages (from-to)258-274
Number of pages17
JournalJournal of Macromarketing
Volume28
Issue number3
DOIs
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Brand names
Expertise
Antidepressants
Prescription
General practitioners
Evaluation
Appropriateness
Medical care
Marketing
Multivariate analysis of variance
Habit
Analysis of variance
Pharmaceuticals
Government
Medical practice
Medical profession
Influencing factors

Cite this

@article{6820aada434c4878bc61856e17a550b8,
title = "A Rose by any other name? The Influence of Brand Name Versus Chemical Differences in the Prescription of Antidepressants: The Role of Expertise",
abstract = "The effect that marketing has had on the prescription decisions of the medical profession is an area of great social and governmental concern and has been the subject of substantial international debate. In this study, the importance of brand name as a factor influencing the prescription habits of general practitioners and psychiatrists is examined. Data on antidepressant prescriptions supplied by the Australian Governments Pharmaceutical Benefit Scheme and results derived from MANOVA and ANOVA analyses suggest that the brand name as much as chemical differences influenced the prescription of choice of antidepressants by both general practitioners and psychiatrists. The use of a well-promoted brand name may be an important evaluation shortcut by both groups regardless of detailed training resulting in medical practices, which may undermine the social imperative of affordable medical care for all. The authors suggest that clinical appropriateness of prescriptions for antidepressants by brand name needs further investigation.",
author = "Anthony Pecotich and Aron O'Cass and Craig Julian",
note = "Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = Journal of Macromarketing. ISSNs: 0276-1467;",
year = "2008",
doi = "10.1177/0276146708320445",
language = "English",
volume = "28",
pages = "258--274",
journal = "Journal of Macromarketing",
issn = "0276-1467",
publisher = "SAGE Publications Inc.",
number = "3",

}

A Rose by any other name? The Influence of Brand Name Versus Chemical Differences in the Prescription of Antidepressants : The Role of Expertise. / Pecotich, Anthony; O'Cass, Aron; Julian, Craig.

In: Journal of Macromarketing, Vol. 28, No. 3, 2008, p. 258-274.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A Rose by any other name? The Influence of Brand Name Versus Chemical Differences in the Prescription of Antidepressants

T2 - The Role of Expertise

AU - Pecotich, Anthony

AU - O'Cass, Aron

AU - Julian, Craig

N1 - Imported on 12 Apr 2017 - DigiTool details were: Journal title (773t) = Journal of Macromarketing. ISSNs: 0276-1467;

PY - 2008

Y1 - 2008

N2 - The effect that marketing has had on the prescription decisions of the medical profession is an area of great social and governmental concern and has been the subject of substantial international debate. In this study, the importance of brand name as a factor influencing the prescription habits of general practitioners and psychiatrists is examined. Data on antidepressant prescriptions supplied by the Australian Governments Pharmaceutical Benefit Scheme and results derived from MANOVA and ANOVA analyses suggest that the brand name as much as chemical differences influenced the prescription of choice of antidepressants by both general practitioners and psychiatrists. The use of a well-promoted brand name may be an important evaluation shortcut by both groups regardless of detailed training resulting in medical practices, which may undermine the social imperative of affordable medical care for all. The authors suggest that clinical appropriateness of prescriptions for antidepressants by brand name needs further investigation.

AB - The effect that marketing has had on the prescription decisions of the medical profession is an area of great social and governmental concern and has been the subject of substantial international debate. In this study, the importance of brand name as a factor influencing the prescription habits of general practitioners and psychiatrists is examined. Data on antidepressant prescriptions supplied by the Australian Governments Pharmaceutical Benefit Scheme and results derived from MANOVA and ANOVA analyses suggest that the brand name as much as chemical differences influenced the prescription of choice of antidepressants by both general practitioners and psychiatrists. The use of a well-promoted brand name may be an important evaluation shortcut by both groups regardless of detailed training resulting in medical practices, which may undermine the social imperative of affordable medical care for all. The authors suggest that clinical appropriateness of prescriptions for antidepressants by brand name needs further investigation.

U2 - 10.1177/0276146708320445

DO - 10.1177/0276146708320445

M3 - Article

VL - 28

SP - 258

EP - 274

JO - Journal of Macromarketing

JF - Journal of Macromarketing

SN - 0276-1467

IS - 3

ER -